Axsome Therapeutics (AXSM) Shares Issued (2022 - 2025)
Historic Shares Issued for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $9.9 million.
- Axsome Therapeutics' Shares Issued fell 2408.21% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.6 million, marking a year-over-year increase of 22279.09%. This contributed to the annual value of $40.8 million for FY2024, which is 8423.81% down from last year.
- Per Axsome Therapeutics' latest filing, its Shares Issued stood at $9.9 million for Q3 2025, which was down 2408.21% from $32.6 million recorded in Q2 2025.
- Axsome Therapeutics' 5-year Shares Issued high stood at $211.3 million for Q2 2023, and its period low was $387000.0 during Q1 2023.
- For the 4-year period, Axsome Therapeutics' Shares Issued averaged around $45.6 million, with its median value being $19.6 million (2025).
- In the last 5 years, Axsome Therapeutics' Shares Issued crashed by 9875.2% in 2023 and then surged by 68568.57% in 2025.
- Axsome Therapeutics' Shares Issued (Quarter) stood at $180.2 million in 2022, then crashed by 81.27% to $33.8 million in 2023, then crashed by 51.35% to $16.4 million in 2024, then crashed by 39.42% to $9.9 million in 2025.
- Its last three reported values are $9.9 million in Q3 2025, $32.6 million for Q2 2025, and $19.6 million during Q1 2025.